Distinguished in Vasculitis

Lindi H. Jiang

180 Fenglin Road, 
Xuhui, CN 
Distinguished in Vasculitis
180 Fenglin Road, 
Xuhui, CN 
OverviewLocationsClinical Research

Overview

Lindi Jiang practices in Xuhui, China. Ms. Jiang is rated as a Distinguished expert by MediFind in the treatment of Vasculitis. Her top areas of expertise are Takayasu Arteritis, Vasculitis, Retroperitoneal Fibrosis, and Ankylosing Spondylitis.

Her clinical research consists of co-authoring 115 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 59 articles and participated in 1 clinical trial in the study of Vasculitis.

Gender
Female

Locations

180 Fenglin Road, Xuhui, 200032, China
Other Locations
138 Yixueyuan Road, Xuhui, 200032, China
12 Middle Wulumuqi Road, Shanghai, 200040, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
Enrollment Status: Terminated
Publish Date: May 16, 2023
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Phase Ⅱ Study to Evaluate the Efficacy and Safety of Hemay005 in the Treatment of Behçet Disease
A Phase Ⅱ Study to Evaluate the Efficacy and Safety of Hemay005 in the Treatment of Behçet Disease
Enrollment Status: Terminated
Publish Date: June 21, 2022
Intervention Type: Drug, Other
Study Drug: Hemay005
Study Phase: Phase 2
View 1 Less Clinical Trial

115 Total Publications

Exploring the genetic interaction between ERAP1/ERAP2 and HLA-B*52:01 in Takayasu arteritis.
Exploring the genetic interaction between ERAP1/ERAP2 and HLA-B*52:01 in Takayasu arteritis.
Journal: Rheumatology (Oxford, England)
Published: April 11, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Jiang's expertise for a condition
ConditionClose
View All 13 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile